Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice

Akiyoshi Saitoh, Hiromu Tominaga, Yasuhiro Ogawa, Yoko Irukayama-Tomobe, Mitsuhiko Yamada, Masashi Yanagisawa, Hiroshi Nagase

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: We previously reported that the novel selective delta opioid receptor (DOP) agonist KNT-127 did not cause convulsions in mice, whereas the prototype DOP agonist SNC80 did. Previous studies have reported that SNC80 caused electroencephalographic (EEG) disturbances in rodents. However, whether KNT-127 affects EEG responses is unknown. Therefore, the present study aimed to compare the effect of KNT-127 on EEG responses with that of SNC80 in mice. Methods: For behavioral experiments, male C57BL6/J mice were injected intraperitoneally with either KNT-127 (30 mg/kg) or SNC80 (30 mg/kg) and monitored for convulsions and subsequent catalepsy-like behavior for 10 min immediately after drug treatment. For EEG recording experiments, EEG electrodes were implanted into the right hemisphere. EEG signals exceeding twice the baseline amplitude were defined as seizure spikes. Results: KNT-127 did not induce convulsive or catalepsy-like behaviors in mice and did not result in seizure spikes, while significantly higher EEG power density was observed at 2 Hz. In contrast, SNC80 administration resulted in convulsive behaviors, seizure spikes, and significantly higher EEG power density between 2 and 10 Hz in mice. Conclusions: In this study, we clearly demonstrated that KNT-127 administration induces neither convulsive effects nor seizure spikes in mice. We propose that KNT-127 should be considered a candidate compound for the development of improved DOP-based psychotropic drug that lack the convulsive properties.

Original languageEnglish (US)
Pages (from-to)350-354
Number of pages5
JournalPharmacological Reports
Volume70
Issue number2
DOIs
StatePublished - Apr 1 2018

Fingerprint

delta Opioid Receptor
Seizures
Catalepsy
Implanted Electrodes
Psychotropic Drugs
KNT 127
Rodentia
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
Pharmaceutical Preparations

Keywords

  • Antidepressant
  • Anxiolytics
  • Convulsion
  • Epileptiform activity
  • Pro-convulsive effect

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice. / Saitoh, Akiyoshi; Tominaga, Hiromu; Ogawa, Yasuhiro; Irukayama-Tomobe, Yoko; Yamada, Mitsuhiko; Yanagisawa, Masashi; Nagase, Hiroshi.

In: Pharmacological Reports, Vol. 70, No. 2, 01.04.2018, p. 350-354.

Research output: Contribution to journalArticle

Saitoh, Akiyoshi ; Tominaga, Hiromu ; Ogawa, Yasuhiro ; Irukayama-Tomobe, Yoko ; Yamada, Mitsuhiko ; Yanagisawa, Masashi ; Nagase, Hiroshi. / Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice. In: Pharmacological Reports. 2018 ; Vol. 70, No. 2. pp. 350-354.
@article{3f5a73046aab4f9f8592427a6e079f7a,
title = "Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice",
abstract = "Background: We previously reported that the novel selective delta opioid receptor (DOP) agonist KNT-127 did not cause convulsions in mice, whereas the prototype DOP agonist SNC80 did. Previous studies have reported that SNC80 caused electroencephalographic (EEG) disturbances in rodents. However, whether KNT-127 affects EEG responses is unknown. Therefore, the present study aimed to compare the effect of KNT-127 on EEG responses with that of SNC80 in mice. Methods: For behavioral experiments, male C57BL6/J mice were injected intraperitoneally with either KNT-127 (30 mg/kg) or SNC80 (30 mg/kg) and monitored for convulsions and subsequent catalepsy-like behavior for 10 min immediately after drug treatment. For EEG recording experiments, EEG electrodes were implanted into the right hemisphere. EEG signals exceeding twice the baseline amplitude were defined as seizure spikes. Results: KNT-127 did not induce convulsive or catalepsy-like behaviors in mice and did not result in seizure spikes, while significantly higher EEG power density was observed at 2 Hz. In contrast, SNC80 administration resulted in convulsive behaviors, seizure spikes, and significantly higher EEG power density between 2 and 10 Hz in mice. Conclusions: In this study, we clearly demonstrated that KNT-127 administration induces neither convulsive effects nor seizure spikes in mice. We propose that KNT-127 should be considered a candidate compound for the development of improved DOP-based psychotropic drug that lack the convulsive properties.",
keywords = "Antidepressant, Anxiolytics, Convulsion, Epileptiform activity, Pro-convulsive effect",
author = "Akiyoshi Saitoh and Hiromu Tominaga and Yasuhiro Ogawa and Yoko Irukayama-Tomobe and Mitsuhiko Yamada and Masashi Yanagisawa and Hiroshi Nagase",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.pharep.2017.08.018",
language = "English (US)",
volume = "70",
pages = "350--354",
journal = "Pharmacological Reports",
issn = "1734-1140",
publisher = "Polish Academy of Sciences Publishing House",
number = "2",

}

TY - JOUR

T1 - Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice

AU - Saitoh, Akiyoshi

AU - Tominaga, Hiromu

AU - Ogawa, Yasuhiro

AU - Irukayama-Tomobe, Yoko

AU - Yamada, Mitsuhiko

AU - Yanagisawa, Masashi

AU - Nagase, Hiroshi

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: We previously reported that the novel selective delta opioid receptor (DOP) agonist KNT-127 did not cause convulsions in mice, whereas the prototype DOP agonist SNC80 did. Previous studies have reported that SNC80 caused electroencephalographic (EEG) disturbances in rodents. However, whether KNT-127 affects EEG responses is unknown. Therefore, the present study aimed to compare the effect of KNT-127 on EEG responses with that of SNC80 in mice. Methods: For behavioral experiments, male C57BL6/J mice were injected intraperitoneally with either KNT-127 (30 mg/kg) or SNC80 (30 mg/kg) and monitored for convulsions and subsequent catalepsy-like behavior for 10 min immediately after drug treatment. For EEG recording experiments, EEG electrodes were implanted into the right hemisphere. EEG signals exceeding twice the baseline amplitude were defined as seizure spikes. Results: KNT-127 did not induce convulsive or catalepsy-like behaviors in mice and did not result in seizure spikes, while significantly higher EEG power density was observed at 2 Hz. In contrast, SNC80 administration resulted in convulsive behaviors, seizure spikes, and significantly higher EEG power density between 2 and 10 Hz in mice. Conclusions: In this study, we clearly demonstrated that KNT-127 administration induces neither convulsive effects nor seizure spikes in mice. We propose that KNT-127 should be considered a candidate compound for the development of improved DOP-based psychotropic drug that lack the convulsive properties.

AB - Background: We previously reported that the novel selective delta opioid receptor (DOP) agonist KNT-127 did not cause convulsions in mice, whereas the prototype DOP agonist SNC80 did. Previous studies have reported that SNC80 caused electroencephalographic (EEG) disturbances in rodents. However, whether KNT-127 affects EEG responses is unknown. Therefore, the present study aimed to compare the effect of KNT-127 on EEG responses with that of SNC80 in mice. Methods: For behavioral experiments, male C57BL6/J mice were injected intraperitoneally with either KNT-127 (30 mg/kg) or SNC80 (30 mg/kg) and monitored for convulsions and subsequent catalepsy-like behavior for 10 min immediately after drug treatment. For EEG recording experiments, EEG electrodes were implanted into the right hemisphere. EEG signals exceeding twice the baseline amplitude were defined as seizure spikes. Results: KNT-127 did not induce convulsive or catalepsy-like behaviors in mice and did not result in seizure spikes, while significantly higher EEG power density was observed at 2 Hz. In contrast, SNC80 administration resulted in convulsive behaviors, seizure spikes, and significantly higher EEG power density between 2 and 10 Hz in mice. Conclusions: In this study, we clearly demonstrated that KNT-127 administration induces neither convulsive effects nor seizure spikes in mice. We propose that KNT-127 should be considered a candidate compound for the development of improved DOP-based psychotropic drug that lack the convulsive properties.

KW - Antidepressant

KW - Anxiolytics

KW - Convulsion

KW - Epileptiform activity

KW - Pro-convulsive effect

UR - http://www.scopus.com/inward/record.url?scp=85042321641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042321641&partnerID=8YFLogxK

U2 - 10.1016/j.pharep.2017.08.018

DO - 10.1016/j.pharep.2017.08.018

M3 - Article

C2 - 29477045

AN - SCOPUS:85042321641

VL - 70

SP - 350

EP - 354

JO - Pharmacological Reports

JF - Pharmacological Reports

SN - 1734-1140

IS - 2

ER -